Title: Sulkowski PL, et al. 2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologousrecombination and induces PARP inhibitor sensitivity. Sci Transl Med. 2017 Feb 1;9(375).
1323-03-1
69134-53-8
35274-05-6
92343-46-9
1391068-16-8
42302-24-9
130551-49-4 | L-4-HYDROXYPHENYL-D4-ALANINE-2,3,3-D3 | AA009BT2 | MFCD01073923
1255237-45-6 | 3-propoxy-1-(tetrahydrofuran-3-yl)but-3-en-2-aMine | AA009C55 | MFCD22571221
1349796-36-6 | XL765 Analogue | AA009CBJ | MFCD18252649
129244-66-2 | Hoechst 33258 analog 6 | AA009C9J | MFCD25976775
1227163-84-9 | (S)-1-(2-(difluoromethyl)pyridin-4-yl)-4-fluoro-1-(3-(pyrimidin-5-yl)phenyl)-1H-isoindol-3-amine | AA009CK3 | MFCD25976574
1352642-37-5 | 2,6-Bis(triMethyltin)-4,8-bis(5-(2-ethylhexyl)thiophen-2-yl)benzo [1,2-b | AA009CYI | MFCD28386086
1257535-41-3 | (5-Chloro-3-methylpyridin-2-yl)methanamine hydrochloride | AA009DAT | MFCD17214210
1219743-33-5 | 5-Amino-N-methyl-1H-pyrazole-3-carboxamide | AA009DOI | MFCD14702862
13600-48-1 | 2-Chloro-6-methyl-4-(trifluoromethyl)nicotinonitrile | AA009DSR | MFCD10568352
1364933-59-4 | JWH 412 | AA009DXZ | MFCD31562800